PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.\', \'National Clinical Research Center for Infectious Diseases, Shenzhen Third People\'s Hospital, Southern University of Science and Technology, Shenzhen, 518112, China.\', \'Savaid Medical School, University of Chinese Academy of Sciences, Beijing, 100049, China.\', \'Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. ye.li@siat.ac.cn.\', \'National Clinical Research Center for Infectious Diseases, Shenzhen Third People\'s Hospital, Southern University of Science and Technology, Shenzhen, 518112, China. szdsyy@aliyun.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12985-021-01617-w
?:hasPublicationType
?:journal
  • Virology journal
is ?:pmid of
?:pmid
?:pmid
  • 34238341
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.053
?:rankingScore_hIndex
  • 65
is ?:relation_isRelatedTo_publication of
?:title
  • Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all